Epilepsy Nervous System Diseases Epilepsy
Conditions
Interventions
This is a two-armed pragmatic trial. The intervention group will receive usual medical care and are additionally given pharmaceutical care, health education and therapeutic drugs monitoring for six mo
Sponsors
Universidad Nacional de Colombia (Colombia)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female, over 18 years 2. Diagnosis of epilepsy for more than a year 3. In treatment with antiepileptic drugs 4. Having at least one crisis in the last year 5. Ability to comply with the directions of the study
Exclusion criteria
Exclusion criteria: 1. Active major psychiatric disorder 2. Physical deficit (e.g., hemiplegia) or mental (e.g., mental retardation), preventing them from answering questionnaires 3. Drug/alcohol dependence 4. Involvement, earlier in the pharmaceutical care program of the institution
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life in Epilepsy Inventory-31 (QOLIE-31). Questionnaire measures will be administered to all participants at the beginning of baseline recording and at the end of treatment (six months). | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaire measures will be administered to all participants at the beginning of baseline recording and at the end of treatment (six months): 1. Liverpool Adverse Events Profile 2. Spanish Center for Epidemiologic Studies, Depression Scale 3. Drug related problems | — |
Countries
Colombia
Outcome results
None listed